Nabel Gary J
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg. 40, Room 4502, MSC-3005, 40 Convent Drive, Bethesda, Maryland 20892-3005, USA.
Nat Med. 2004 Feb;10(2):135-41. doi: 10.1038/nm990.
Advances in immunology and molecular genetics have accelerated our understanding of the genetic and cellular basis of many diseases. At the same time, remarkable progress in recombinant DNA technology has enabled the development of molecular and cellular treatments for infectious diseases, inherited disorders and cancer. This Perspective is intended to give a sample of the progress over the past ten years in cellular, genetic and immune therapy of disease. During this time, monoclonal antibody technology and cellular transplantation have begun to come of age in biomedicine. Innovations in gene delivery have not only catalyzed the nascent field of human gene therapy, but may also ultimately impact human health by advancing recombinant vaccine technology.
免疫学和分子遗传学的进展加速了我们对许多疾病的遗传和细胞基础的理解。与此同时,重组DNA技术取得的显著进展推动了针对传染病、遗传性疾病和癌症的分子与细胞治疗方法的发展。本综述旨在展示过去十年间疾病的细胞、遗传和免疫治疗方面取得的一些进展。在此期间,单克隆抗体技术和细胞移植在生物医学领域已逐渐成熟。基因递送方面的创新不仅催化了人类基因治疗这一新兴领域,还可能通过推动重组疫苗技术的发展最终影响人类健康。